A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

计划入组 40 人 · 首次发布于 2020 年 6 月 9 日

CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]

计划入组 851 人 · 首次发布于 2024 年 9 月 23 日

Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis

计划入组 420 人 · 首次发布于 2007 年 1 月 25 日

DSG3-CAART

DSG3+DSG1 CAART

DSG3/1 CAART

Cabaletta Bio to Present New CABA-201 Clinical Data at ACR Convergence 2024

Scientists Successfully Reprogram Pathogenic T Cells Into Protective Regulatory Cells for Autoimmune Disease Treatment